Rheumatoid Arthritis Hayley Evans, CMCBI, King’s College London, UK

Slides:



Advertisements
Similar presentations
RHEUMATOID ARTHRITIS MUHAMMAD ADEEL (BIOT 412) Human Diseases Presentation.
Advertisements

Wrap-Up and Post Course Self Assessment Dr. Diane Lacaille.
3 Arthritis Partnership for Environmental Education and Rural Health Texas A&M University
Joint Replacement Stephanie Arrington. Joint Replacement  Research suggests that more than a million people a year are getting a total joint replacement.
Tena Trbojević Mentor: A. Žmegač Horvat
Rheumatoid Arthritis By, Marissa Miuccio.
Measuring Signs and Symptoms in Rheumatoid Arthritis David R. Karp, MD, PhD Chief, Rheumatic Diseases UT Southwestern Medical Center David R. Karp, MD,
+ Rheumatoid Arthritis Jocelin Olmos & Matt Scroggy.
All About Rheumatoid Arthritis
Rheumatoid Arthritis Anila Malik GPVTS. Aims To cover the following: What is RA? Diagnostic criteria and clinical features Rheumatoid Factor Investigations.
Rheumatoid Arthritis Susan Buffo,CathyYanney,Rowena Windsor ABE 61 June 1, 2010.
Recomendations for the medicamentous treatment of chronic inflammatory rheumatic disease pain Dušan Logar Dpt.of Rheumatology, University Clinical Centre,
RHEUMATOID ARTHRITIS By: Julie Le and Mary Le 5/2/12 4 th pd.
 Inflammatory arthritis and an autoimmune disease  Immune system attacks the body’s own tissues  Fluid builds up in the joints, causing pain that’s.
DAREDEVILS: Prajwal Acharya, Cristina Johnson, Julie David, Jen Masciovecchio, Yen Phan.
Overview of Arthritis Brought to you in collaboration by: 1. Arthritis Foundation Tennessee Chapter 2. Tennessee Department of Health 3. University of.
OSTEOARTHRITIS. Osteoarthritis (OA) is a common, degenerative disease, which is characterized by local degeneration of joint cartilage and new bone formation.
Kara Kliethermes Jim Shinaberry December 6, 2012.
Systemic Lupus Erythematosus and Rheumatoid arthritis 醫學一 B 王樂詠 B 許伊婷.
Rheumatoid Arthritis (RA) By: Leon Richardson Period
DR.A.Tahamoli Rudsari.  Rheumatoid arthritis (RA) is a chronic multisystem disease of unknown cause.  Although there are a variety of systemic manifestations,
The Skeletal System Stephen Pou & Rahul Rai Human Biology 6-Wolsko.
Part B Autoimmune Diseases Part B Autoimmune Diseases Effector mechanisms of autoimmune disease Endocrine glands as special targets.
Rheumatoid Arthritis Sean Stives. What is it? Chronic disease affecting mainly synovial joints (usually in the hands and feet) Causes pain and stiffening.
Melanie Dunn 9/20/2011.  Rheumatoid arthritis (RA) is a chronic disease that leads to inflammation of the joints and surrounding tissues that can also.
Copyright © 2004 Pearson Education, Inc., publishing as Benjamin Cummings Human Anatomy & Physiology, Sixth Edition Elaine N. Marieb PowerPoint ® Lecture.
Physiological Diseases of the human Skeleton. Inflammatory Disorders of joints Joint pain and discomfort can be caused by many factors Bursitis Arthritis.
Rheumatoid Arthritis.
Rheumatoid Arthritis Dr Chandini Rao Consultant Rheumatologist.
Copyright PEER.tamu.edu.  Do you know anyone that has arthritis?  Both humans and animals can get arthritis.  What is arthritis?  Arthritis.
BY PROF. AZZA EL-MEDANY DR. OSAMA YOUSIF General Features & Conditions to use antirheumatic Low doses are commonly used early in the course of the disease.
R HEUMATOID F ACTOR ( RF ). Rheumatoid arthritis is a chronic inflammatory disorder that affects all joints either in hands or feet and other areas of.
Disease modified Anti-rheumatic drugs ( DMARD)
AUTOIMMUNITY. Autoimmunity Breaking of self tolerance Both B and T cells may be involved (however, most are antibody mediated)
Homeostatic Imbalance In the joints!. Bursitis also called “water on the knee”. Caused by inflammation of bursae, or synovial membrane.
Joint Injuries Arthritis By: Alessandro Iunni, Simon Da Silva, and Dylan Mugford.
Rheumatoid arthritis (RA).  Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally.
Introduction to collagen-vascular diseases. Definition: Rheumatologic (or Rheumatic) Disease: diseases characterized by pain and inflammation in joints.
CATEGORY: IMMUNE DYSFUNCTION Systemic Lupus Erythematosus (SLE) Angela Midgley, University of Liverpool, UK S YSTEMIC L UPUS E RYTHEMATOSUS © The copyright.
4. Rheumatologic conditions
Juvenile Idiopathic Arthritis
Section 23.3 Other Chronic Diseases Objectives
Osteoarthritis vs Rheumatoid Arthritis
Cytokines: Introduction
Rheumatoid Arthritis: Management and New Therapies
Tests for Rheumatoid Arthritis
Systemic Lupus Erythematosus (SLE)
From: Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic AgentsA Cost-Effectiveness.
Immunodeficiency: Antibody
Arthritis.
Osteoarthritis By the end of this PowerPoint you will be able to….
Unit 3 Autoimmunity Part 1 Introduction
Autoimmunity: Introduction
B Cells: Regulatory (Bregs)
Treatment Goal of treatment reduce inflammation and pain
B-CELL SUBSETS DIFFERENCES IN INFLAMMATORY RHEUMATIC DISEASES
Autoimmune Diseases Autoimmune Diseases Presented By Dr. Manal Yassin.
Managing Rheumatoid arthritis
54 Osteoarthritis.
CD46: role in multiple sclerosis
Wrap-Up and Post Course Self Assessment
ARTHRITIS A number of diseases that result in the destruction of articular cartilage.
Section 23.3 Other Chronic Diseases Objectives
Low-dose glucocorticoid chronotherapy in rheumatoid arthritis (RA) include the night-time-release prednisone, a timing drug release formulation with administration.
Stem cells What is stem cells therapy ? A stem cell is a type of cell not specialized to perform a specific role. Stem cell therapy uses stem cells to.
Stem cells What is stem cells therapy ? A stem cell is a type of cell not specialized to perform a specific role. Stem cell therapy uses stem cells to.
Overview of Arthritis Brought to you in collaboration by:
Suggested therapeutic management according to subtypes and severity of rheumatic immune-related adverse events (irAE). *Add-on therapy with DMARDs (disease-modifying.
Presentation transcript:

Rheumatoid Arthritis Hayley Evans, CMCBI, King’s College London, UK CATEGORY: IMMUNE DYSFUNCTION RHEUMATOID ARTHRITIS Rheumatoid Arthritis Hayley Evans, CMCBI, King’s College London, UK Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting the joints. It occurs in 0.5-1% of people in the Western world, predominately women between 30-50 years of age, and has a high familial association. The disease leads to decreased life expectancy and increases morbidity amongst sufferers. Although the aetiology of the disease is unknown, there are a number of environmental and genetic risk factors associated with disease incidence (smoking, obesity, HLA type, etc.). Once the disease is triggered, immune cells migrate into the joints where they produce large quantities of immune mediators (cytokines/chemokines) leading to the activation and recruitment of more immune cells into the tissue. Hyperplasia of the normally thin synovial membrane occurs and fluid collects in the narrow joint space causing swelling and impaired mobility. Inflammation can vary in severity between patients but is chronic and progressive in nature leading to joint damage and bone erosion. The presence of self-reactive antibodies in RA suggests that the body’s normal self/non-self recognition system is disrupted in the diseased state, but whether this is the cause or simply a consequence of inflammation is unknown. It also appears that the normal regulatory mechanisms used by the body are not sufficient to control the disease. Instead the treatment of RA currently relies on the augmentation and blockade of different aspects of the immune response through drug administration. At present it is not possible to cure RA but induction of remission is achieved in some patients. A stepwise therapeutic regimen is used ranging from non-steroidal anti- inflammatories, to disease-modifying anti-rheumatic drugs (DMARDs) and finally the specific blockade of certain immune cells or pro-inflammatory mediators using biologics. © The copyright for this work resides with the author